DRUG PROFILE

DRUG NAME (GENERIC):

__________________________________________________________________________________________

CLASS OF THE DRUG:

__________________________________________________________________________________________

MOA:

__________________________________________________________________________________________
__________________________________________________________________________________________
__________________________________________________________________________________________
__________________________________________________________________________________________
__________________________________________________________________________________________
__________________________________________________________________________________________
__________________________________________________________________________________________
__________________________________________________________________________________________
__________________________________________________________________________________________

PHARMACOKINETICS:

Route of Admin Onset of Action Duration of Action

ABSORPTION AND DISTRIBUTION:

Cross
% Plasma Cross Blood
Placental Volume of Peak Plasma
Protein Brain Barrier
Barrier Distribution Level
Binding (Y/N)
(Y/N)

13
METABOLISM AND ELIMINATION:

Organ of Active Metabolite

Half Life Route of Excretion
Metabolism (if any)

PHARMACOLOGICAL USES:

Effect on Other Spectrum (if

Sr. No. Therapeutic Uses
Organ System antibiotic)

DIRECTION FOR USE:

__________________________________________________________________________________________
__________________________________________________________________________________________
__________________________________________________________________________________________

13
ADVERSE DRUG REACTIONS:

__________________________________________________________________________________________
__________________________________________________________________________________________
__________________________________________________________________________________________
__________________________________________________________________________________________
__________________________________________________________________________________________

DRUG INTERACTIONS:

__________________________________________________________________________________________
__________________________________________________________________________________________
__________________________________________________________________________________________
__________________________________________________________________________________________
__________________________________________________________________________________________
__________________________________________________________________________________________
__________________________________________________________________________________________

PRODUCT SPECIFICATIONS:

S. Dosage
Trade Name Manufacturer Strength Price
No. Form

DOSE:

__________________________________________________________________________________________
__________________________________________________________________________________________
__________________________________________________________________________________________
__________________________________________________________________________________________

_____________________________ _____________________________

13
 II. DRUG PROFILE
DRUG NAME (GENERIC):

__________________________________________________________________________________________

CLASS OF THE DRUG:

__________________________________________________________________________________________

MOA:

__________________________________________________________________________________________
__________________________________________________________________________________________
__________________________________________________________________________________________
__________________________________________________________________________________________
__________________________________________________________________________________________
__________________________________________________________________________________________
__________________________________________________________________________________________
__________________________________________________________________________________________
__________________________________________________________________________________________

PHARMACOKINETICS:

Route of Admin Onset of Action Duration of Action

ABSORPTION AND DISTRIBUTION:

Cross
% Plasma Cross Blood
Placental Volume of Peak Plasma
Protein Brain Barrier
Barrier Distribution Level
Binding (Y/N)
(Y/N)

13
METABOLISM AND ELIMINATION:

Organ of Active Metabolite

Half Life Route of Excretion
Metabolism (if any)

PHARMACOLOGICAL USES:

Effect on Other Spectrum (if

Sr. No. Therapeutic Uses
Organ System antibiotic)

DIRECTION FOR USE:

__________________________________________________________________________________________
__________________________________________________________________________________________
__________________________________________________________________________________________

13
ADVERSE DRUG REACTIONS:

__________________________________________________________________________________________
__________________________________________________________________________________________
__________________________________________________________________________________________
__________________________________________________________________________________________
__________________________________________________________________________________________

DRUG INTERACTIONS:

__________________________________________________________________________________________
__________________________________________________________________________________________
__________________________________________________________________________________________
__________________________________________________________________________________________
__________________________________________________________________________________________
__________________________________________________________________________________________
__________________________________________________________________________________________

PRODUCT SPECIFICATIONS:

S. Dosage
Trade Name Manufacturer Strength Price
No. Form

DOSE:

__________________________________________________________________________________________
__________________________________________________________________________________________
__________________________________________________________________________________________
__________________________________________________________________________________________

Student Pharmacist Supervisor Pharmacist

_____________________________ _____________________________

13
 III. DRUG PROFILE
DRUG NAME (GENERIC):

__________________________________________________________________________________________

CLASS OF THE DRUG:

__________________________________________________________________________________________

MOA:

__________________________________________________________________________________________
__________________________________________________________________________________________
__________________________________________________________________________________________
__________________________________________________________________________________________
__________________________________________________________________________________________
__________________________________________________________________________________________
__________________________________________________________________________________________
__________________________________________________________________________________________
__________________________________________________________________________________________

PHARMACOKINETICS:

Route of Admin Onset of Action Duration of Action

ABSORPTION AND DISTRIBUTION:

Cross
% Plasma Cross Blood
Placental Volume of Peak Plasma
Protein Brain Barrier
Barrier Distribution Level
Binding (Y/N)
(Y/N)

13
METABOLISM AND ELIMINATION:

Organ of Active Metabolite

Half Life Route of Excretion
Metabolism (if any)

PHARMACOLOGICAL USES:

Effect on Other Spectrum (if

Sr. No. Therapeutic Uses
Organ System antibiotic)

DIRECTION FOR USE:

__________________________________________________________________________________________
__________________________________________________________________________________________
__________________________________________________________________________________________

13
ADVERSE DRUG REACTIONS:

__________________________________________________________________________________________
__________________________________________________________________________________________
__________________________________________________________________________________________
__________________________________________________________________________________________
__________________________________________________________________________________________

DRUG INTERACTIONS:

__________________________________________________________________________________________
__________________________________________________________________________________________
__________________________________________________________________________________________
__________________________________________________________________________________________
__________________________________________________________________________________________
__________________________________________________________________________________________
__________________________________________________________________________________________

PRODUCT SPECIFICATIONS:

S. Dosage
Trade Name Manufacturer Strength Price
No. Form

DOSE:

__________________________________________________________________________________________
__________________________________________________________________________________________
__________________________________________________________________________________________
__________________________________________________________________________________________

Student Pharmacist Supervisor Pharmacist

_____________________________ _____________________________

13